Phase III trial of the efficacy and tolerability of bucindolol in patients with acute myocardial and heart failure

Trial Profile

Phase III trial of the efficacy and tolerability of bucindolol in patients with acute myocardial and heart failure

Discontinued
Phase of Trial: Phase III

Latest Information Update: 05 Nov 2010

At a glance

  • Drugs Bucindolol (Primary)
  • Indications Heart failure; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms BEAT
  • Most Recent Events

    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top